BALEN JOHN V
Known title: DirectorCIK: 0001181211
BALEN JOHN V's purchase track record
How the stock did after each of BALEN JOHN V's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since August 30, 2021
Stock higher 6 months later
20%
3 months: 20%
Median 6-month return
-62.1%
3 months: -41.8%
Beat the S&P 500
20%
median -57.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/7/2022 | CDLX | $61K | +85.4% | +39.0% | +8.7% |
| 8/12/2022 | CDLX | $84K | -64.1% | -62.1% | -4.4% |
| 5/27/2022 | CDLX | $137K | -49.4% | -85.4% | -3.2% |
| 5/9/2022 | CDLX | $88K | -41.8% | -85.3% | -4.6% |
| 8/30/2021 | CDLX | $90K | -23.5% | -36.1% | -3.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CDLX | ▲ Buy | Option Exercise | 6,465 | — | 5/24/2023 | View on chart |
| CDLX | ▲ Buy | Open Market | 3,000 | $11K | 11/9/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 6,000 | $24K | 11/8/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 6,000 | $25K | 11/7/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 2,000 | $34K | 8/15/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,000 | $17K | 8/12/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,999 | $33K | 8/12/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1 | $17 | 8/12/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 2,000 | $55K | 5/27/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,000 | $27K | 5/27/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,000 | $27K | 5/27/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,000 | $27K | 5/27/2022 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 1,701 | $0 | 5/21/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 900 | $27K | 5/10/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 100 | $3K | 5/10/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,000 | $30K | 5/10/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 600 | $17K | 5/9/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 100 | $3K | 5/9/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 300 | $9K | 5/9/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 1,000 | $90K | 8/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CDLX: No company news in last 7 days
The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.
CDLX: No company news in last 7 days. The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.